# Acupuncture Prevents Chemobrain in Breast Cancer Patients

> **NCT02457039** · NA · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 93 (actual)

## Conditions studied

- Chemo-brain
- Drug-Related Side Effects and Adverse Reactions
- Mild Cognitive Impairment
- Breast Cancer

## Interventions

- **PROCEDURE:** Dense cranial electroacupuncture stimulation
- **PROCEDURE:** Body acupuncture
- **PROCEDURE:** Least acupuncture stimulation
- **DRUG:** Cytoxan-containing chemotherapy regimens

## Key facts

- **NCT ID:** NCT02457039
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2019-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02457039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02457039, "Acupuncture Prevents Chemobrain in Breast Cancer Patients". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT02457039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*